Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher Causey currently holds 0 shares of UNITED THERAPEUTICS CORP (UTHR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Causey has been a net neutral trader of UTHR stock. They have purchased $0 and sold $0 worth of shares.
Christopher Causey serves as Executive at UNITED THERAPEUTICS CORP (UTHR). They have executed 0 insider transactions totaling $0 over their tenure at the company.
Christopher Causey holds the position of Executive at UNITED THERAPEUTICS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for null years and currently hold a stake valued at $0.
Christopher Causey has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
Transaction details are not currently available.
Christopher Causey currently owns 0 shares of UNITED THERAPEUTICS CORP (UTHR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher Causey's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher Causey has 0 Form 4 filings on record as an insider at UNITED THERAPEUTICS CORP.
Set alerts for Christopher Causey and 40,000+ other insiders.